To further explore the biological significance of GOT2 in the progression of hepatocellular carcinoma, we first transfected siRNAs targeting GOT2 (siGOT2) or negative control siRNA (siNC) in HEK293 cells and verified their knockdown efficiency by RT-qPCR (Fig. 9B). This evidence concerns the gene GOT2 and hepatocellular carcinoma.